Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piyanuch Kongtim

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2014
Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantationBetul Oran, Piyanuch Kongtim, Uday Popat, et al.
American Journal of Hematology|July 1, 2020
Haploidentical transplants for patients with graft failure after the first allograftPiyanuch Kongtim, Maria Bittencourt, Samer A Srour, et al.
Blood|December 12, 2019
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?Stefan O Ciurea, Piyanuch Kongtim, Ankur Varma, et al.
Blood Advances|September 2, 2021
Treatment of allosensitized patients receiving allogeneic transplantationStefan O Ciurea, Monzr M Al Malki, Piyanuch Kongtim, et al.
Frontiers in Immunology|October 31, 2022
Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCyJun Zou, Piyanuch Kongtim, Samer A Srour, et al.
Haematologica|August 26, 2021
Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantationJun Zou, Piyanuch Kongtim, Betül Oran, et al.
American Journal of Hematology|March 6, 2024
Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AMLStefan O Ciurea, Piyanuch Kongtim, Samer Srour, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2015
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell TransplantationStefan O Ciurea, Peter F Thall, Denái R Milton, et al.
Blood Advances|September 8, 2021
Mismatch in SIRPα, a regulatory protein in innate immunity, is associated with chronic GVHD in hematopoietic stem cell transplantationRima M Saliba, Uri Greenbaum, Qing Ma, et al.
Frontiers in Immunology|July 25, 2022
SIRPα Mismatch Is Associated With Relapse Protection and Chronic Graft-Versus-Host Disease After Related Hematopoietic Stem Cell Transplantation for Lymphoid MalignanciesRima M Saliba, Samer A Srour, Uri Greenbaum, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2014
Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantationBetul Oran, Piyanuch Kongtim, Uday Popat, et al.
American Journal of Hematology|July 1, 2020
Haploidentical transplants for patients with graft failure after the first allograftPiyanuch Kongtim, Maria Bittencourt, Samer A Srour, et al.
Blood|December 12, 2019
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?Stefan O Ciurea, Piyanuch Kongtim, Ankur Varma, et al.
Blood Advances|September 2, 2021
Treatment of allosensitized patients receiving allogeneic transplantationStefan O Ciurea, Monzr M Al Malki, Piyanuch Kongtim, et al.
Frontiers in Immunology|October 31, 2022
Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCyJun Zou, Piyanuch Kongtim, Samer A Srour, et al.
Haematologica|August 26, 2021
Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantationJun Zou, Piyanuch Kongtim, Betül Oran, et al.
American Journal of Hematology|March 6, 2024
Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AMLStefan O Ciurea, Piyanuch Kongtim, Samer Srour, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2015
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell TransplantationStefan O Ciurea, Peter F Thall, Denái R Milton, et al.
Blood Advances|September 8, 2021
Mismatch in SIRPα, a regulatory protein in innate immunity, is associated with chronic GVHD in hematopoietic stem cell transplantationRima M Saliba, Uri Greenbaum, Qing Ma, et al.
Frontiers in Immunology|July 25, 2022
SIRPα Mismatch Is Associated With Relapse Protection and Chronic Graft-Versus-Host Disease After Related Hematopoietic Stem Cell Transplantation for Lymphoid MalignanciesRima M Saliba, Samer A Srour, Uri Greenbaum, et al.
Pageof 7